Contact
searchSearch
HMP Global
Sponsored

Optimizing Outcomes in Complex PAD: Dr. Nagarsheth on DETOUR Integration and Patient Selection

Khanjan Nagarsheth, MD, MBA, RPVI
09/23/2025

Join Dr. KJ Nagarsheth as he reflects on his experience with PTAB Therapy using the DETOUR™ system. Dr. Nagarsheth discusses the types of patients he considers for this innovative percutaneous bypass solution and what would help streamline DETOUR integration into vascular practices.


Stay in the Know

Vascular Disease Management Newsletter

News

Peripheral IVL
Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter Launched in Europe to Transform Treatment of Difficult-to-Cross Calcified Lesions
09/16/2025
“The Shockwave Javelin Peripheral IVL catheter helps address one of the most persistent technical barriers in complex below the knee (BTK) revascularization – the ‘device-uncrossable’ calcified lesion,” said Dr. Narayanan Thulasidasan
“The Shockwave Javelin Peripheral IVL catheter helps address one of the most persistent technical barriers in complex below the knee (BTK) revascularization – the ‘device-uncrossable’ calcified lesion,” said Dr. Narayanan Thulasidasan
“The Shockwave Javelin...
09/16/2025
Cath Lab Digest
Embolization
Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolization to Treat Knee Osteoarthritis in Europe
09/15/2025
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc....
09/15/2025
Vascular Disease Management
Robotic Systems
Microbot Medical Receives FDA 510(k) Clearance for Its Liberty Endovascular Robotic System
09/08/2025
The LIBERTY pivotal study showed 100% success in the robotic navigation to target, and zero device-related adverse events. The study also showed a 92% relative reduction in physician radiation exposure.
The LIBERTY pivotal study showed 100% success in the robotic navigation to target, and zero device-related adverse events. The study also showed a 92% relative reduction in physician radiation exposure.
The LIBERTY pivotal study showed...
09/08/2025
Cath Lab Digest
PAD Pulse Alliance
Peripheral Artery Disease (PAD) Awareness Month Urges Screening and Advocacy in National Effort to Prevent Amputations
09/04/2025
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed...
09/04/2025
Cath Lab Digest
Pulmonary Embolism
Imperative Care Announces FDA Clearance of Symphony Thrombectomy System, the First Large-Bore Continuous Vacuum System for Treatment of Pulmonary Embolism
09/04/2025
This clearance expands the use of Symphony — previously for the treatment of venous thrombosis — to now include PE, providing a comprehensive solution to effectively and efficiently treat the full spectrum of venous thromboembolism (VTE)...
This clearance expands the use of Symphony — previously for the treatment of venous thrombosis — to now include PE, providing a comprehensive solution to effectively and efficiently treat the full spectrum of venous thromboembolism (VTE)...
This clearance expands the use...
09/04/2025
Cath Lab Digest
Renal Denervation
Medtronic Receives Approval for Symplicity Spyral Renal Denervation System in Japan
09/02/2025
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure...
09/02/2025
Cath Lab Digest
News
Final Patient Treated in ZENITH® FENESTRATED+ Endovascular Graft Clinical Study
08/28/2025
CAUTION – INVESTIGATIONAL DEVICE. Limited by United States law to investigational use.     Bloomington, Ind. — Cook Medical has enrolled the final patient in the global clinical study of the ZENITH® FENESTRATED+ Endovascular...
CAUTION – INVESTIGATIONAL DEVICE. Limited by United States law to investigational use.     Bloomington, Ind. — Cook Medical has enrolled the final patient in the global clinical study of the ZENITH® FENESTRATED+ Endovascular...
CAUTION – INVESTIGATIONAL...
08/28/2025
Vascular Disease Management
Bioresorbable Scaffolds
Abbott's Esprit BTK Everolimus-Eluting Resorbable Scaffold System Receives CE Mark, Pioneering a New Era in Peripheral Vascular Treatment
08/26/2025
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Designed to treat blocked...
08/26/2025
Cath Lab Digest
Liquid Embolics
Instylla Gains U.S. FDA Premarket Approval for Embrace™ Hydrogel Embolic System
08/07/2025
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025...
08/07/2025
Vascular Disease Management
Embolization
Embolx Launches Sniper G3: Revolutionizing Embolization With Enhanced Efficiency, Ease of Use, and Extended Shelf Life
07/28/2025
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025...
07/28/2025
Vascular Disease Management

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use